Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by …
SGC Kroeze, M Pavic, K Stellamans, Y Lievens… - The lancet …, 2023 - thelancet.com
Stereotactic body radiotherapy (SBRT) for patients with metastatic cancer, especially when
characterised by a low tumour burden (ie, oligometastatic disease), receiving targeted …
characterised by a low tumour burden (ie, oligometastatic disease), receiving targeted …
[HTML][HTML] Toxicity of concurrent stereotactic radiotherapy and targeted therapy or immunotherapy: a systematic review
Background and purpose Both stereotactic radiotherapy (SRT) and immune-or targeted
therapy play an increasingly important role in personalized treatment of metastatic disease …
therapy play an increasingly important role in personalized treatment of metastatic disease …
Gut commensal derived-valeric acid protects against radiation injuries
Y Li, J Dong, H Xiao, S Zhang, B Wang, M Cui… - Gut microbes, 2020 - Taylor & Francis
Background Hematopoietic and intestinal systems side effects are frequently found in
patients who suffered from accidental or medical radiation exposure. In this case, we …
patients who suffered from accidental or medical radiation exposure. In this case, we …
Stereotactic ablative radiotherapy for the management of spinal metastases: a review
RM Glicksman, MC Tjong, WFP Neves-Junior… - JAMA …, 2020 - jamanetwork.com
Importance Rising cancer incidence combined with improvements in systemic and local
therapies extending life expectancy are translating into more patients with spinal …
therapies extending life expectancy are translating into more patients with spinal …
The risk of radiation necrosis following stereotactic radiosurgery with concurrent systemic therapies
To investigate late toxicity among patients with newly-diagnosed brain metastases
undergoing stereotactic radiosurgery (SRS) with concurrent systemic therapies with or …
undergoing stereotactic radiosurgery (SRS) with concurrent systemic therapies with or …
Phase 1 trial of sorafenib and stereotactic body radiation therapy for hepatocellular carcinoma
AM Brade, S Ng, J Brierley, J Kim, R Dinniwell… - International Journal of …, 2016 - Elsevier
Purpose To determine the maximally tolerated dose of sorafenib delivered before, during,
and after stereotactic body radiation therapy (SBRT) in hepatocellular carinoma (HCC) …
and after stereotactic body radiation therapy (SBRT) in hepatocellular carinoma (HCC) …
Management of early-stage non-small cell lung cancer using stereotactic ablative radiotherapy: controversies, insights, and changing horizons
The use of stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung
cancer is growing rapidly, particularly since it has become the recommended therapy for …
cancer is growing rapidly, particularly since it has become the recommended therapy for …
Radiation dose‐volume effects for liver SBRT
Stereotactic body radiation therapy (SBRT) has emerged as an effective, noninvasive
treatment option for primary liver cancer and metastatic disease occurring in the liver …
treatment option for primary liver cancer and metastatic disease occurring in the liver …
[HTML][HTML] Safety and tolerability of metastasis-directed radiation therapy in the era of evolving systemic, immune, and targeted therapies
AbstractPurpose: Systemic, immune, and target therapies are growing in use in the
management of metastatic cancers. The aim of this review was to describe up-to-date …
management of metastatic cancers. The aim of this review was to describe up-to-date …
Gastrointestinal toxicities with combined antiangiogenic and stereotactic body radiation therapy
Combining the latest targeted biologic agents with the most advanced radiation
technologies has been an exciting development in the treatment of cancer patients …
technologies has been an exciting development in the treatment of cancer patients …